TITLE 77: PUBLIC HEALTH
CHAPTER X: DEPARTMENT OF HUMAN SERVICES
SUBCHAPTER e: CONTROLLED SUBSTANCES ACTIVITIES
PART 2080 ELECTRONIC PRESCRIPTION MONITORING PROGRAM
SECTION 2080.325 PEER REVIEW SUBCOMMITTEE
Section 2080.325 Peer Review Subcommittee
The PMPAC is authorized to have a standing subcommittee. This subcommittee shall be a five member peer review subcommittee. The peer review subcommittee shall advise the PMP on matters relating to the advisory committee's field of competence, establish a formal peer review of professional performance of prescribers and dispensers, and develop communications to transmit to prescribers and dispensers. The deliberations, information and communications of the peer review subcommittee are privileged and confidential and shall not be disclosed in any manner except in accordance with the Act.
a) The Clinical Director shall appoint the five members of the peer review subcommittee.
b) The peer review subcommittee shall consist of the following:
1) three physicians of the PMPAC; and
2) two pharmacists of the PMPAC.
c) Technical advisors from State medical and pharmacy schools with no voting authority may be appointed to the peer review subcommittee to aid the voting members on an as needed basis.
d) The peer review subcommittee shall meet, at a minimum, quarterly. The scheduling of these meetings should be set to allow the meetings to occur the month prior to the publicly scheduled meeting of the PMPAC.
e) The peer review subcommittee shall periodically review the data contained within the prescription monitoring program to identify those prescribers or dispensers who may be prescribing or dispensing outside the currently established professional standards for the prescriber's or dispenser's field of practice and for the type of medication (e.g., opioids) or type of care (e.g., hospice) applicable to the prescription under review.
f) The peer review subcommittee shall identify prescribers or dispensers who may be prescribing outside of the currently accepted medical standards in the course of their professional practice and send the identified prescriber or dispenser a request for information regarding his or her prescribing or dispensing practices. A prescriber or dispenser shall have 30 days to respond to the request for information.
g) The peer review subcommittee shall refer a prescriber or dispenser to the Department of Financial and Professional Regulation:
1) if a prescriber or dispenser does not respond to three successive requests for information;
2) if, in the opinion of a majority of members of the peer review subcommittee, the prescriber or dispenser does not have a satisfactory explanation for the practices identified by the peer review subcommittee or the prescriber or dispenser does not have a satisfactory explanation for the practices identified by the peer review subcommittee in its request for information; or
3) if, following communications with the peer review subcommittee, the prescriber or dispenser does not sufficiently rectify the practices identified in the request for information in the opinion of the majority of the members of the peer review subcommittee.
h) The peer review subcommittee shall prepare an annual report starting on July 1, 2017. The report shall contain the following information:
1) the number of times the peer review subcommittee was convened;
2) the number of prescribers or dispensers who were reviewed by the peer review subcommittee;
3) the number of requests for information sent out by the subcommittee; and
4) the number of prescribers or dispensers referred to the Department of Financial and Professional Regulation.
i) The following process shall be followed to allow PMP data to be publicly disseminated:
1) all data formats considered for dissemination shall be presented to the peer review subcommittee by its chairperson;
2) all deliberations shall be recorded to ensure accuracy of the minutes for each meeting;
3) Based upon the deliberations of the peer review subcommittee regarding the data to be disseminated, a summary report shall be written by the chairperson and forwarded to the General Counsel for review and approval of dissemination by the General Counsel, Chief of Staff and Secretary.
4) Official direction for the final processing and/or dissemination of the data will be sent via the General Counsel, Chief of Staff or Secretary's office to the chairperson of the PMPAC peer review subcommittee who will then disseminate the data accordingly.
(Source: Added at 41 Ill. Reg. 11909, effective September 13, 2017)